These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1389529)

  • 21. Screening for anxiety and depression in primary care with the Duke Anxiety-Depression Scale.
    Parkerson GR; Broadhead WE
    Fam Med; 1997 Mar; 29(3):177-81. PubMed ID: 9085098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening for mental disorders in cancer, cardiovascular and musculoskeletal diseases. Comparison of HADS and GHQ-12.
    Härter M; Woll S; Wunsch A; Bengel J; Reuter K
    Soc Psychiatry Psychiatr Epidemiol; 2006 Jan; 41(1):56-62. PubMed ID: 16328751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The accuracy of HADS and GHQ-12 in detecting psychiatric morbidity in breast cancer patients].
    Krespi Boothby MR; Hill J; Holcombe C; Clark L; Fisher J; Salmon P
    Turk Psikiyatri Derg; 2010; 21(1):49-59. PubMed ID: 20204904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of three psychiatric screening tests using receiver operating characteristic (ROC) analysis.
    Weinstein MC; Berwick DM; Goldman PA; Murphy JM; Barsky AJ
    Med Care; 1989 Jun; 27(6):593-607. PubMed ID: 2725088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of mental health screening tools for detecting antenatal depression and anxiety disorders in South African women.
    van Heyningen T; Honikman S; Tomlinson M; Field S; Myer L
    PLoS One; 2018; 13(4):e0193697. PubMed ID: 29668725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic validity of the Hospital Anxiety and Depression Scale (HADS) in cancer and palliative settings: a meta-analysis.
    Mitchell AJ; Meader N; Symonds P
    J Affect Disord; 2010 Nov; 126(3):335-48. PubMed ID: 20207007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening for depression in terminally ill cancer patients in Japan.
    Akechi T; Okuyama T; Sugawara Y; Shima Y; Furukawa TA; Uchitomi Y
    J Pain Symptom Manage; 2006 Jan; 31(1):5-12. PubMed ID: 16442477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prevalence of depressive disorders in children and adolescents attending primary care. A survey with the Aquitaine Sentinelle Network].
    Mathet F; Martin-Guehl C; Maurice-Tison S; Bouvard MP
    Encephale; 2003; 29(5):391-400. PubMed ID: 14615688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validity and reliability of the Hospital Anxiety and Depression Scale in a hypertrophic cardiomyopathy clinic: the HADS in a cardiomyopathy population.
    Poole NA; Morgan JF
    Gen Hosp Psychiatry; 2006; 28(1):55-8. PubMed ID: 16377366
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A psychometric evaluation of the French Canadian version of the Hospital Anxiety and Depression Scale in a large primary care population.
    Roberge P; Doré I; Menear M; Chartrand E; Ciampi A; Duhoux A; Fournier L
    J Affect Disord; 2013 May; 147(1-3):171-9. PubMed ID: 23218249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Feasibility and diagnostic accuracy of early mood screening to diagnose persisting clinical depression/anxiety disorder after stroke.
    Lees R; Stott DJ; Quinn TJ; Broomfield NM
    Cerebrovasc Dis; 2014; 37(5):323-9. PubMed ID: 24903316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of the Hospital Anxiety and Depression Scale in patients with epilepsy.
    Wiglusz MS; Landowski J; Michalak L; Cubała WJ
    Epilepsy Behav; 2016 May; 58():97-101. PubMed ID: 27064829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validation of the Polish version of the Hospital Anxiety and Depression Scale for anxiety disorders in patients with epilepsy.
    Wiglusz MS; Landowski J; Cubała WJ
    Epilepsy Behav; 2018 Jul; 84():162-165. PubMed ID: 29803946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening for depressive and anxiety disorders among adolescents in Indonesia: Formal validation of the centre for epidemiologic studies depression scale - revised and the Kessler psychological distress scale.
    Tran TD; Kaligis F; Wiguna T; Willenberg L; Nguyen HTM; Luchters S; Azzopardi P; Fisher J
    J Affect Disord; 2019 Mar; 246():189-194. PubMed ID: 30583144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The cut-off points of the Depression and Somatic Symptoms Scale and the Hospital Anxiety and Depression Scale in detecting non-full remission and a current major depressive episode.
    Hung CI; Liu CY; Wang SJ; Yao YC; Yang CH
    Int J Psychiatry Clin Pract; 2012 Mar; 16(1):33-40. PubMed ID: 22122659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Operating characteristics of depression and anxiety disorder phenotype dimensions and trait neuroticism: a theoretical examination of the fear and distress disorders from the Netherlands study of depression and anxiety.
    Tully PJ; Wardenaar KJ; Penninx BW
    J Affect Disord; 2015 Mar; 174():611-8. PubMed ID: 25577156
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Hospital Anxiety and Depression Scale (HADS) and the 9-item Patient Health Questionnaire (PHQ-9) as screening instruments for depression in patients with cancer.
    Hartung TJ; Friedrich M; Johansen C; Wittchen HU; Faller H; Koch U; Brähler E; Härter M; Keller M; Schulz H; Wegscheider K; Weis J; Mehnert A
    Cancer; 2017 Nov; 123(21):4236-4243. PubMed ID: 28654189
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening instruments for a population of older adults: The 10-item Kessler Psychological Distress Scale (K10) and the 7-item Generalized Anxiety Disorder Scale (GAD-7).
    Vasiliadis HM; Chudzinski V; Gontijo-Guerra S; Préville M
    Psychiatry Res; 2015 Jul; 228(1):89-94. PubMed ID: 25956759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic efficiency of the Hospital Anxiety and Depression Scale in women with early stage breast cancer.
    Love AW; Kissane DW; Bloch S; Clarke D
    Aust N Z J Psychiatry; 2002 Apr; 36(2):246-50. PubMed ID: 11982548
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incremental predictive value of screening for anxiety and depression beyond current type 2 diabetes risk models: a prospective cohort study.
    Atlantis E; Ghassem Pour S; Girosi F
    BMJ Open; 2018 Jan; 8(1):e018255. PubMed ID: 29362254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.